More good news
Interesting to note that Daiichi Sanyo gained approval last year to bring an oncolytic virus to market in Japan - the first such approval in Japan. The approval (conditional) was granted on the basis of one single arm ph 2 study with no control group.
https://pharmaphorum.com/news/daiichi-sankyo-claims-first-okay-for-cancer-killing-virus-in-japan/
I have previously suggested Daiichi as a possible partner for Imugene - with regard to Her-Vaxx. Daiichi is trying hard to expand their oncology portfolio. It’s a fair bet they would be interested in CF33 too.
Just a thought. Late night here for me though, so I’m off to bed. Wake me if anything else exciting happens….
Cheers
Dave
- Forums
- ASX - By Stock
- IMU
- Ann: Oncolytic Virotherapy CF33 Patent Granted in Japan
Ann: Oncolytic Virotherapy CF33 Patent Granted in Japan, page-26
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.7¢ |
Change
-0.002(3.39%) |
Mkt cap ! $418.9M |
Open | High | Low | Value | Volume |
6.0¢ | 6.2¢ | 5.7¢ | $1.565M | 26.21M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 3118428 | 5.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.8¢ | 893590 | 29 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 3113969 | 0.057 |
15 | 2428465 | 0.056 |
24 | 3821880 | 0.055 |
11 | 2060287 | 0.054 |
5 | 311036 | 0.053 |
Price($) | Vol. | No. |
---|---|---|
0.058 | 893590 | 29 |
0.059 | 823029 | 11 |
0.060 | 1200609 | 8 |
0.061 | 561000 | 4 |
0.062 | 436412 | 6 |
Last trade - 13.45pm 15/07/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |